Volume 2, Issue 4 (Multidisciplinary Cancer Investigation 2018)                   Multidiscip Cancer Investig 2018, 2(4): 16-24 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ceriani M C, Lendez P A, Martinez Cuesta L, Nieto Farias M V, Shen H M, Buehring G C et al . Bovine Leukemia Virus Presence in Breast Tissue of Argentinian Females and Its Association With Cell Proliferation and Prognosis Markers. Multidiscip Cancer Investig. 2018; 2 (4) :16-24
URL: http://mcijournal.com/article-1-208-en.html
Abstract:   (4112 Views)
Bovine leukemia virus (BLV) causes enzootic bovine leukemia, andis closely related to human T-lymphotropic virus type 1. It expresses microRNAs of unknown function and codes Tax, the protein that mediates malignant transformation. BLV is capable of infecting B- and T-lymphocytes, endothelial cells, and mammary epithelial cells of cattle. Several studies demonstrated the presence of BLV DNA in human tissue, and it is significantly associated with breast cancer in case-control studies using in situ PCR, a highly sensitive and specific technique. The current study was the first report of BLV DNA detection by in situ PCR in tissue from Argentinian females with a diagnosis of breast cancer.
Methods: In situ PCR was done to detect BLV DNA in 85 human FFPE breast cancer tissue samples. The association of BLV DNA and expression of Ki67 and Her-2 was assessed.
Results: BLV DNA presence could be determined in 22.6% of the analyzed samples, and its presence was associated with an increase of the expression and prognosis markers Ki67 (P=0.009) and HER-2 (P=0.044) determined by conventional immunohistochemistry. No statistical significance was observed between the presence or absence of hormonal receptors and the presence of BLV DNA.
Conclusions: The obtained results support the idea that BLV might play a role in malignant tissue transformation.
Full-Text [PDF 540 kb]   (1575 Downloads)    
Type of Study: Original/Research Article | Subject: Other
Received: 2018/09/1 | Accepted: 2018/09/22 | ePublished: 2018/10/1

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb